The ImmunoTOX multidisciplinary board: A descriptive study of collaborative management of immune-related adverse events

Volume: 30, Pages: v719 - v719
Published: Oct 1, 2019
Abstract
Background null The adverse events generated by immunotherapies are characterized by their wide diversity, unpredictability and reversibility by steroid used, and requires a delicate management. A collaborative organization of immunological toxicology management called ImmunoTOX (iTox) has been set up at Gustave Roussy to support physicians in their routine practice. null null null Methods null Descriptive study of all consecutive advice given...
Paper Details
Title
The ImmunoTOX multidisciplinary board: A descriptive study of collaborative management of immune-related adverse events
Published Date
Oct 1, 2019
Volume
30
Pages
v719 - v719
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.